Express Scripts (NASDAQ: ESRX) is one of 127 public companies in the “MEDICAL CARE” industry, but how does it contrast to its peers? We will compare Express Scripts to similar businesses based on the strength of its valuation, analyst recommendations, earnings, dividends, risk, profitability and institutional ownership.
Risk & Volatility
Express Scripts has a beta of 0.94, suggesting that its share price is 6% less volatile than the S&P 500. Comparatively, Express Scripts’ peers have a beta of 1.25, suggesting that their average share price is 25% more volatile than the S&P 500.
This is a summary of recent ratings for Express Scripts and its peers, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Express Scripts Competitors||714||3436||5285||127||2.50|
Express Scripts presently has a consensus target price of $82.65, indicating a potential upside of 11.60%. As a group, “MEDICAL CARE” companies have a potential upside of 6.71%. Given Express Scripts’ higher possible upside, equities analysts clearly believe Express Scripts is more favorable than its peers.
Valuation and Earnings
This table compares Express Scripts and its peers revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Express Scripts||$100.06 billion||$4.52 billion||9.43|
|Express Scripts Competitors||$7.60 billion||$240.26 million||-12,529.74|
Express Scripts has higher revenue and earnings than its peers. Express Scripts is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.
Insider & Institutional Ownership
89.4% of Express Scripts shares are owned by institutional investors. Comparatively, 60.8% of shares of all “MEDICAL CARE” companies are owned by institutional investors. 0.7% of Express Scripts shares are owned by company insiders. Comparatively, 15.9% of shares of all “MEDICAL CARE” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
This table compares Express Scripts and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Express Scripts Competitors||-67.98%||-652.47%||-22.79%|
Express Scripts beats its peers on 8 of the 13 factors compared.
Express Scripts Company Profile
Express Scripts, Inc. is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM). PBM segment’s services include retail network pharmacy management and retail drug card programs, home delivery services, specialty benefit services, patient care contact centers, benefit plan design and consultation, drug formulary management, compliance and therapy management programs, information reporting and analysis programs, rebate programs, and electronic claims processing and drug utilization review. EM segment’s services include distribution of pharmaceuticals and medical supplies to providers and clinics and healthcare account administration and implementation of consumer-directed healthcare solutions.
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.